FDA announces streamlined EUA amendment for certain molecular test developers to pool specimens as part of a serial testing program.
Read more: FDA Announces New Streamlined Approach to Add Pooled Serial Screening Claims to Certain Authorized Tests for Use in Serial Testing Programs